Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
Federal Trade Commission
Citi
Moodys
McKinsey
US Department of Justice
Cipla
Dow
Harvard Business School
Colorcon

Generated: August 22, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Which drugs does patent 6,124,363 protect, and when does it expire?


Patent ► Subscribe protects TIKOSYN and is included in one NDA. There has been one Paragraph IV challenge on Tikosyn.

This patent has fifty-two patent family members in forty-six countries.

Summary for Patent: ► Subscribe

Title: Dofetilide polymorphs
Abstract:The invention relates to the substantially pure dofetilide polymorphs P162, P162a and P143, and to processes for the preparation of, compositions containing and to the uses of, such polymorphs.
Inventor(s): Appleby; Ian Colin (Sandwich, GB), Newbury; Trevor Jack (Sandwich, GB), Nichols; Gary (Sandwich, GB)
Assignee: Pfizer Inc. (New York, NY)
Application Number:09/423,986
Patent Claim Types:
see list of patent claims
Compound; Process; Composition; Dosage form; Use;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Pfizer
TIKOSYN
dofetilide
CAPSULE;ORAL020931-001Oct 1, 1999ABRXYesNo► Subscribe► Subscribe
Pfizer
TIKOSYN
dofetilide
CAPSULE;ORAL020931-002Oct 1, 1999ABRXYesNo► Subscribe► Subscribe
Pfizer
TIKOSYN
dofetilide
CAPSULE;ORAL020931-003Oct 1, 1999ABRXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: ► Subscribe

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9722662Oct 27, 1997
PCT Information
PCT FiledOctober 09, 1998PCT Application Number:PCT/EP98/06641
PCT Publication Date:May 06, 1999PCT Publication Number: WO99/21829

International Patent Family for Patent: ► Subscribe

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Saudi Arabia1168► Subscribe
Portugal1027329► Subscribe
Poland197379► Subscribe
Poland340805► Subscribe
Peru122199► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
Cerilliant
Cantor Fitzgerald
Citi
Covington
Merck
Deloitte
Harvard Business School
Cipla
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot